Saturday, March 03, 2007 3:28:41 PM
That is...not until Merck USA needs to carry out a massive research project in South Africa, using Emory University in Atlanta, with which Dnaprint has a collaborative agreement in place and made its proprietary platform available. Remember, they could have gone to Phase III as Pfizer is doing, but they decided to go to Phase IIb. Why? Maybe they got a little DnaPrnt up their sleeve. Populations, safety, efficacy...etc...JMHO
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM